Immucell
ICCC • NASDAQ
Immucell is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO F. Olivier Te Boekhorst, with a market cap of $65.0M.
Market Cap$65.0M
Employees80.0
CEOF. Olivier Te Boekhorst
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 13, 2026 · in a monthQ1 2026
Financials
Immucell FAQ
Common questions about Immucell
Immucell is scheduled to report earnings for Q1 2026 on May 13, 2026.
Immucell has approximately 80 employees.